Pharmalot... Pharmalittle... Good Morning

Good morning, everyone, and how are you today? Another busy day is unfolding here on the Pharmalot corporate campus, where the maintence crew is tending to a number of important projects. As for us, we are quaffing the usual cup of stimulation - we are still enjoying Hazelnut Cinnamon Creme - and invite you to join us with a cup of your own. Meanwhile, we also have much to do. So here are some tidbits. Have a great day and feel free to drop us a line at pharmalot@gmail.com when something interesting arises... Indian Regulator To Review J&J Appeal On License Cancellation (Business Standard) Pfizer Settles With Canadians Over Neurontin Side Effects (The Toronto Sun) Astellas Looks To Sell Dermatology Assets (Reuters) AMA House Overrides Its Council And Calls Obestity A Disease (MedPage Today) Glaxo May Sell Bloodthinners To Aspen Pharmacare (Pharma Times) Bayer To Add Jobs At Animal Health Plant In Missouri (St. Joseph News-Press) Protalix Signs Supply Deal For Gaucher Drug With Brazil (Associated Press) German Regulator Rebuffs Sanofi...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs